by Jazzmin Huber | Mar 24, 2023 | Clinical Trials, Research
A clinical trial in the USA is recruiting patients with osteosarcoma and other cancers to test a new drug complex called GD2 SADA: 177 Lu DOTA. This drug uses a new technology where it can disassemble and reassemble itself. By changing the way it’s constructed it can...
by Jazzmin Huber | Feb 23, 2023 | Research
In recent years there has been an increase in cancer treatments that target the immune system. So far, these therapies have not been effective in treating osteosarcoma (OS). Researchers are now trying to understand why these treatments are not working. A recent study...
by Jazzmin Huber | Feb 9, 2023 | Clinical Trials, Research
Dr. Matteo Trucco, from Cleveland Clinic Children’s, has launched a sarcoma clinical trial. This clinical trial, based in the USA, aims to see if a drug called disulfiram could be repurposed to be used in sarcoma treatment. Sarcomas are a group of cancers which...
by Katie Nightingale | Feb 2, 2023 | Research
In the last 30 years there has been very little change to osteosarcoma (OS) treatment. We are dedicated to changing this. Through the Myrovlytis Trust, we fund research into OS, with a focus on finding new treatments. We are pleased to announce we have awarded funding...
by Jazzmin Huber | Jan 13, 2023 | Research, Resources and Support
Our work in osteosarcoma (OS) started in 2021, with many months dedicated to talking with experts, patients and other charities. These initial conversations helped us to identify how best we could support patients and their families. 2022 was the year we made these...
by Jazzmin Huber | Dec 6, 2022 | Clinical Trials, Research
In November 2022 we attended the Connective Tissue Oncology Society (CTOS) meeting. This meeting brought together clinicians, researchers and patient advocates dedicated to improving outcomes in sarcoma. In this blog we highlight some of the talks with a focus on...
